Advertisement

Advertisement

ANIX Stock Latest News

Anixa Biosciences announces agreement with Cytovance Biologics

The FlyAnixa Biosciences announces agreement with Cytovance Biologics

Anixa Biosciences Shareholders Back Board and Compensation

PremiumCompany Announcements

Anixa Biosciences Shareholders Back Board and Compensation

2M ago

Anixa Biosciences says Korean MOIP issues Notice of Allowance for new patent

PremiumThe Fly

Anixa Biosciences says Korean MOIP issues Notice of Allowance for new patent

2M ago

Anixa Advances Ovarian Cancer CAR-T With Higher Dosing

PremiumCompany Announcements

Anixa Advances Ovarian Cancer CAR-T With Higher Dosing

3M ago

Anixa provides update on Phase 1 ovarian cancer CAR-T clinical trial

PremiumThe Fly

Anixa provides update on Phase 1 ovarian cancer CAR-T clinical trial

3M ago

Anixa Biosciences receives USAN Council approval for novel CAR-T therapy name

PremiumThe FlyAnixa Biosciences receives USAN Council approval for novel CAR-T therapy name

3M ago

Anixa Biosciences granted patent for breast cancer vaccine technology in Mexico

The Fly

Anixa Biosciences granted patent for breast cancer vaccine technology in Mexico

3M ago

Anixa announces transfer of IND for breast cancer vaccine from Cleveland Clinic

The Fly

Anixa announces transfer of IND for breast cancer vaccine from Cleveland Clinic

4M ago

Anixa Biosciences Reports Positive Phase 1 Trial Results

PremiumCompany Announcements

Anixa Biosciences Reports Positive Phase 1 Trial Results

5M ago

Anixa Biosciences says all primary endpoints met in breast cancer vaccine trial

PremiumThe Fly

Anixa Biosciences says all primary endpoints met in breast cancer vaccine trial

5M ago

Anixa Biosciences’ CAR-T therapy granted WHO approval of non-proprietary name

PremiumThe Fly

Anixa Biosciences’ CAR-T therapy granted WHO approval of non-proprietary name

5M ago

Anixa Biosciences awarded patent covering breast cancer vaccine technology

PremiumThe Fly

Anixa Biosciences awarded patent covering breast cancer vaccine technology

6M ago

Anixa Biosciences executes data transfer with Cleveland Clinic

PremiumThe FlyAnixa Biosciences executes data transfer with Cleveland Clinic

6M ago

Anixa awarded patent in China covering breast cancer vaccine technology

The Fly

Anixa awarded patent in China covering breast cancer vaccine technology

6M ago

Anixa Biosciences completes patient visit in breast cancer vaccine trial

The Fly

Anixa Biosciences completes patient visit in breast cancer vaccine trial

7M ago

Anixa announces final results from Phase 1 trial of breast cancer vaccine

PremiumThe Fly

Anixa announces final results from Phase 1 trial of breast cancer vaccine

7M ago

Anixa Biosciences: Promising Clinical Progress and Financial Stability Underpin Buy Rating

PremiumRatings

Anixa Biosciences: Promising Clinical Progress and Financial Stability Underpin Buy Rating

8M ago

Anixa Biosciences files $200M mixed securities shelf

PremiumThe Fly

Anixa Biosciences files $200M mixed securities shelf

8M ago

Promising Advancements and Strategic Positioning Propel Anixa Biosciences to a Buy Rating

PremiumRatings

Promising Advancements and Strategic Positioning Propel Anixa Biosciences to a Buy Rating

8M ago

Anixa completes dosing of fourth cohort in Phase 1 trial of CAR-T/CER-T therapy

PremiumThe FlyAnixa completes dosing of fourth cohort in Phase 1 trial of CAR-T/CER-T therapy

8M ago

Anixa receives notice of allowance in China for cancer vaccine technology patent

The Fly

Anixa receives notice of allowance in China for cancer vaccine technology patent

8M ago

Anixa Biosciences treats second patient in fourth ovarian cancer trial cohort

The Fly

Anixa Biosciences treats second patient in fourth ovarian cancer trial cohort

8M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >